Advertisement
Screener

Pulse Biosciences, Inc. (PLSE) Operating Income

Pulse Biosciences, Inc. Operating Income

Pulse Biosciences, Inc. (PLSE) reported Operating Income of -$25.27 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2026-08-06

  • Pulse Biosciences, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$25.27M.
  • Pulse Biosciences, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$19.15M.
  • Pulse Biosciences, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$18.25M.
  • Pulse Biosciences, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$20.37M.
  • Pulse Biosciences, Inc. operating income (loss) for fiscal 2025 was -$76.94M.
  • Pulse Biosciences, Inc. operating income (loss) for fiscal 2024 was -$56.26M.
  • Pulse Biosciences, Inc. operating income (loss) for fiscal 2023 was -$43.57M.
  • Pulse Biosciences, Inc. operating income (loss) for fiscal 2022 was -$58.06M.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 6 monthOperating Income (Loss) 7 monthOperating Income (Loss) 9 monthOperating Income (Loss) 12 monthOperating Income (Loss) 12 month as first filed
2026-06-30-$25.27M
10-Q · filed 2026-08-06
-$44.42M
10-Q · filed 2026-08-06
-$62.67M
derived: sum of 3 quarters · filed 2026-08-06
-$83.04M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31-$19.15M
10-Q · filed 2026-05-14
-$37.40M
derived: sum of 2 quarters · filed 2026-05-14
-$57.77M
derived: sum of 3 quarters · filed 2026-05-14
-$78.05M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$18.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
-$38.62M
derived: sum of 2 quarters · filed 2026-02-19
-$58.90M
derived: sum of 3 quarters · filed 2026-08-06
-$76.94M
10-K · filed 2026-02-19
2025-09-30-$20.37M
10-Q · filed 2025-11-05
-$40.64M
derived: sum of 2 quarters · filed 2026-08-06
-$58.69M
10-Q · filed 2025-11-05
-$78.95M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$20.27M
10-Q · filed 2026-08-06
-$38.32M
10-Q · filed 2026-08-06
-$58.58M
derived: sum of 3 quarters · filed 2026-08-06
-$72.23M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$18.04M
10-Q · filed 2026-05-14
-$38.30M
derived: sum of 2 quarters · filed 2026-05-14
-$51.96M
derived: sum of 3 quarters · filed 2026-05-14
-$63.69M
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31-$20.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
-$33.92M
derived: sum of 2 quarters · filed 2026-02-19
-$45.64M
derived: sum of 3 quarters · filed 2026-02-19
-$56.26M
10-K · filed 2026-02-19
2024-09-30-$13.65M
10-Q · filed 2025-11-05
-$25.38M
derived: sum of 2 quarters · filed 2025-11-05
-$36.00M
10-Q · filed 2025-11-05
-$48.53M
derived: sum of 4 quarters · filed 2025-11-05
2024-06-30-$11.73M
10-Q · filed 2025-08-12
-$22.34M
10-Q · filed 2025-08-12
-$34.87M
derived: sum of 3 quarters · filed 2025-08-12
-$46.13M
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31-$10.62M
10-Q · filed 2025-05-08
-$23.15M
derived: sum of 2 quarters · filed 2025-05-08
-$34.40M
derived: sum of 3 quarters · filed 2025-05-08
-$44.63M
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31-$12.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
-$23.79M
derived: sum of 2 quarters · filed 2025-03-31
-$34.01M
derived: sum of 3 quarters · filed 2025-03-31
-$43.57M
10-K · filed 2025-03-31
2023-09-30-$11.25M
10-Q · filed 2024-10-30
-$21.48M
derived: sum of 2 quarters · filed 2024-10-30
-$31.04M
10-Q · filed 2024-10-30
-$39.79M
derived: sum of 4 quarters · filed 2024-10-30
2023-06-30-$10.23M
10-Q · filed 2024-08-19
-$19.79M
10-Q · filed 2024-08-19
-$28.53M
derived: sum of 3 quarters · filed 2024-08-19
-$46.56M
derived: sum of 4 quarters · filed 2024-08-19
2023-03-31-$9.56M
10-Q · filed 2024-05-07
-$18.31M
derived: sum of 2 quarters · filed 2024-05-07
-$36.33M
derived: sum of 3 quarters · filed 2024-05-07
-$50.35M
derived: sum of 4 quarters · filed 2024-05-07
2022-12-31-$8.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
-$26.77M
derived: sum of 2 quarters · filed 2024-03-28
-$40.78M
derived: sum of 3 quarters · filed 2024-03-28
-$58.06M
10-K · filed 2024-03-28
2022-09-30-$18.02M
10-Q · filed 2023-11-13
-$32.04M
derived: sum of 2 quarters · filed 2023-11-13
-$49.31M
10-Q · filed 2023-11-13
-$64.72M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30-$14.01M
10-Q · filed 2023-08-10
-$31.29M
10-Q · filed 2023-08-10
-$46.70M
derived: sum of 3 quarters · filed 2023-08-10
-$60.97M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31-$17.27M
10-Q · filed 2023-05-11
-$32.68M
derived: sum of 2 quarters · filed 2023-05-11
-$46.96M
derived: sum of 3 quarters · filed 2023-05-11
-$61.76M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31-$15.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
-$29.68M
derived: sum of 2 quarters · filed 2023-03-31
-$44.49M
derived: sum of 3 quarters · filed 2023-03-31
-$63.01M
10-K · filed 2023-03-31
2021-09-30-$14.27M
10-Q · filed 2022-11-10
-$29.08M
derived: sum of 2 quarters · filed 2022-11-10
-$47.60M
10-Q · filed 2022-11-10
-$61.36M
derived: sum of 4 quarters · filed 2023-03-31
2021-06-30-$14.81M
10-Q · filed 2022-08-10
-$33.33M
10-Q · filed 2022-08-10
-$47.09M
derived: sum of 3 quarters · filed 2023-03-31
-$59.99M
derived: sum of 4 quarters · filed 2023-03-31
2021-03-31-$18.52M
10-Q · filed 2022-05-11
-$32.28M
derived: sum of 2 quarters · filed 2023-03-31
-$45.19M
derived: sum of 3 quarters · filed 2023-03-31
2020-12-31-$13.76M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
-$26.66M
derived: sum of 2 quarters · filed 2023-03-31
-$49.97M
10-K · filed 2023-03-31
-$49.85M
10-K · filed 2021-03-12
2020-09-30-$12.90M
10-Q · filed 2021-11-15
-$36.21M
10-Q · filed 2021-11-15
2019-12-31-$13.79M
10-K · filed 2020-03-16
-$25.53M
derived: sum of 2 quarters · filed 2020-03-16
-$36.89M
derived: sum of 3 quarters · filed 2020-03-16
-$47.95M
10-K · filed 2022-03-31
-$46.97M
10-K · filed 2020-03-16
2019-09-30-$11.75M
10-K · filed 2020-03-16
-$23.11M
derived: sum of 2 quarters · filed 2020-03-16
-$33.18M
derived: sum of 3 quarters · filed 2020-03-16
-$42.14M
derived: sum of 4 quarters · filed 2020-03-16
2019-06-30-$11.36M
10-K · filed 2020-03-16
-$21.44M
derived: sum of 2 quarters · filed 2020-03-16
-$30.39M
derived: sum of 3 quarters · filed 2020-03-16
-$41.15M
derived: sum of 4 quarters · filed 2020-03-16
2019-03-31-$10.08M
10-K · filed 2020-03-16
-$19.03M
derived: sum of 2 quarters · filed 2020-03-16
-$29.79M
derived: sum of 3 quarters · filed 2020-03-16
-$38.95M
derived: sum of 4 quarters · filed 2020-03-16
2018-12-31-$8.95M
10-K · filed 2020-03-16
-$19.71M
derived: sum of 2 quarters · filed 2020-03-16
-$28.88M
derived: sum of 3 quarters · filed 2020-03-16
-$37.55M
10-K · filed 2021-03-12
2018-09-30-$10.76M
10-K · filed 2020-03-16
-$19.92M
derived: sum of 2 quarters · filed 2020-03-16
-$28.59M
derived: sum of 3 quarters · filed 2020-03-16
-$37.30M
derived: sum of 4 quarters · filed 2020-03-16
2018-06-30-$9.16M
10-K · filed 2020-03-16
-$17.83M
derived: sum of 2 quarters · filed 2020-03-16
-$26.53M
derived: sum of 3 quarters · filed 2020-03-16
-$34.02M
derived: sum of 4 quarters · filed 2020-03-16
2018-03-31-$8.67M
10-K · filed 2020-03-16
-$17.37M
derived: sum of 2 quarters · filed 2020-03-16
-$24.86M
derived: sum of 3 quarters · filed 2020-03-16
-$31.04M
derived: sum of 4 quarters · filed 2020-03-16
2017-12-31-$8.70M
10-K · filed 2019-03-14
-$16.19M
derived: sum of 2 quarters · filed 2019-03-14
-$22.37M
derived: sum of 3 quarters · filed 2019-03-14
-$25.57M
10-K · filed 2020-03-16
2017-09-30-$7.49M
10-K · filed 2019-03-14
-$13.67M
derived: sum of 2 quarters · filed 2019-03-14
-$16.86M
derived: sum of 3 quarters · filed 2019-03-14
-$19.67M
derived: sum of 4 quarters · filed 2019-03-14
2017-06-30-$6.18M
10-K · filed 2019-03-14
-$9.38M
derived: sum of 2 quarters · filed 2019-03-14
-$12.19M
derived: sum of 3 quarters · filed 2019-03-14
-$14.95M
derived: sum of 4 quarters · filed 2019-03-14
2017-03-31-$3.20M
10-K · filed 2019-03-14
-$6.01M
derived: sum of 2 quarters · filed 2019-03-14
-$8.77M
derived: sum of 3 quarters · filed 2019-03-14
-$11.03M
derived: sum of 4 quarters · filed 2019-03-14
2016-12-31-$2.81M
10-K · filed 2018-03-16
-$5.58M
derived: sum of 2 quarters · filed 2018-03-16
-$7.83M
derived: sum of 3 quarters · filed 2018-03-16
-$9.52M
10-K · filed 2019-03-14
2016-09-30-$2.77M
10-K · filed 2018-03-16
-$5.03M
derived: sum of 2 quarters · filed 2018-03-16
-$6.71M
10-Q · filed 2016-11-14
-$8.24M
derived: sum of 4 quarters · filed 2018-03-16
2016-06-30-$2.26M
10-K · filed 2018-03-16
-$3.94M
10-Q · filed 2016-08-10
-$5.48M
derived: sum of 3 quarters · filed 2018-03-16
-$6.71M
derived: sum of 4 quarters · filed 2018-03-16
2016-03-31-$1.68M
10-K · filed 2018-03-16
-$3.22M
derived: sum of 2 quarters · filed 2018-03-16
-$4.45M
derived: sum of 3 quarters · filed 2018-03-16
-$5.41M
derived: sum of 4 quarters · filed 2018-03-16
2015-12-31-$1.53M
10-K · filed 2017-03-20
-$2.77M
derived: sum of 2 quarters · filed 2017-03-20
-$3.73M
derived: sum of 3 quarters · filed 2017-03-20
-$4.47M
10-K · filed 2018-03-16
2015-09-30-$1.23M
10-K · filed 2017-03-20
-$2.19M
derived: sum of 2 quarters · filed 2017-03-20
-$2.93M
10-Q · filed 2016-11-14
2015-06-30-$956.00K
10-K · filed 2017-03-20
-$1.70M
10-Q · filed 2016-08-10
2015-03-31-$743.00K
10-K · filed 2017-03-20
2014-12-31-$300.00K
10-K · filed 2017-03-20

Similar stocks

Stock NameCountryMarket CapPE Ratio
iRhythm Holdings, Inc. (IRTC)United States$3.651B-281.06
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85
Heartflow, Inc. (HTFL)United States$4.225B
AtriCure, Inc. (ATRC)United States$3.089B
HAEMONETICS CORP (HAE)United States$4.821B36.52
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
TELEFLEX INC (TFX)United States$5.093B-5.44
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
NovoCure Ltd (NVCR)$1.886B-11.87